Online Only Articles

Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial

National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.235937